BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37515701)

  • 81. Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
    Leonardi MC; Tomio L; Radice D; Takanen S; Bonzano E; Alessandro M; Ciabattoni A; Ivaldi GB; Bagnardi V; Alessandro O; Francia CM; Fodor C; Miglietta E; Veronesi P; Galimberti VE; Orecchia R; Tagliaferri L; Vidali C; Massaccesi M; Guenzi M; Jereczek-Fossa BA;
    Ann Surg Oncol; 2020 Mar; 27(3):752-762. PubMed ID: 31732946
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expert consensus on re-irradiation for recurrent glioma.
    Krauze AV; Attia A; Braunstein S; Chan M; Combs SE; Fietkau R; Fiveash J; Flickinger J; Grosu A; Howard S; Nieder C; Niyazi M; Rowe L; Smart DD; Tsien C; Camphausen K
    Radiat Oncol; 2017 Dec; 12(1):194. PubMed ID: 29195507
    [TBL] [Abstract][Full Text] [Related]  

  • 83. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
    Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
    [TBL] [Abstract][Full Text] [Related]  

  • 84. When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
    Gentilini O; Botteri E; Rotmensz N; Santillo B; Peradze N; Saihum RC; Intra M; Luini A; Galimberti V; Goldhirsch A; Veronesi U
    Ann Oncol; 2007 Mar; 18(3):468-72. PubMed ID: 17158776
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome.
    Botteri E; Rotmensz N; Sangalli C; Toesca A; Peradze N; De Oliveira Filho HR; Sagona A; Intra M; Veronesi P; Galimberti V; Luini A; Veronesi U; Gentilini O
    Ann Oncol; 2009 Jun; 20(6):1008-12. PubMed ID: 19150942
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer.
    Fowble B
    Acta Oncol; 1999; 38 Suppl 13():9-17. PubMed ID: 10612491
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.
    Fisher B; Bryant J; Dignam JJ; Wickerham DL; Mamounas EP; Fisher ER; Margolese RG; Nesbitt L; Paik S; Pisansky TM; Wolmark N;
    J Clin Oncol; 2002 Oct; 20(20):4141-9. PubMed ID: 12377957
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Which patients don't need a tumor-bed boost after whole-breast radiotherapy?
    Kurtz JM
    Strahlenther Onkol; 2001 Jan; 177(1):33-6. PubMed ID: 11200110
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence.
    Kolberg HC; Niesing H; Vaidya JS; Akpolat-Basci L; Maguz A; Hoffmann O; Loevey G; Stephanou M; Kolberg-Liedtke C
    Anticancer Res; 2023 Feb; 43(2):733-739. PubMed ID: 36697057
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
    Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
    Morrow M; Van Zee KJ; Solin LJ; Houssami N; Chavez-MacGregor M; Harris JR; Horton J; Hwang S; Johnson PL; Marinovich ML; Schnitt SJ; Wapnir I; Moran MS
    J Clin Oncol; 2016 Nov; 34(33):4040-4046. PubMed ID: 27528719
    [TBL] [Abstract][Full Text] [Related]  

  • 93. External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study.
    Pashtan IM; Recht A; Ancukiewicz M; Brachtel E; Abi-Raad RF; D'Alessandro HA; Levy A; Wo JY; Hirsch AE; Kachnic LA; Goldberg S; Specht M; Gadd M; Smith BL; Powell SN; Taghian AG
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e271-7. PubMed ID: 22652104
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer.
    Hardy-Abeloos C; Xiao J; Oh C; Barbee D; Perez CA; Oratz R; Schnabel F; Axelrod D; Guth A; Braunstein LZ; Khan A; Choi JI; Gerber N
    Breast Cancer Res Treat; 2023 Feb; 198(1):43-51. PubMed ID: 36604352
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.
    Morrow M; Van Zee KJ; Solin LJ; Houssami N; Chavez-MacGregor M; Harris JR; Horton J; Hwang S; Johnson PL; Marinovich ML; Schnitt SJ; Wapnir I; Moran MS
    Ann Surg Oncol; 2016 Nov; 23(12):3801-3810. PubMed ID: 27527714
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications.
    Krauss DJ; Kestin LL; Mitchell C; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):731-40. PubMed ID: 15465189
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
    Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy.
    Rudloff U; Brogi E; Reiner AS; Goldberg JI; Brockway JP; Wynveen CA; McCormick B; Patil S; Van Zee KJ
    Ann Surg; 2010 Apr; 251(4):583-91. PubMed ID: 20224381
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery.
    Salvadori B; Marubini E; Miceli R; Conti AR; Cusumano F; Andreola S; Zucali R; Veronesi U
    Br J Surg; 1999 Jan; 86(1):84-7. PubMed ID: 10027366
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins.
    Shimizu N; Myojin M; Tamura M; Nishiyama N; Yamashiro K; Yuyama Y; Okazaki Y; Suzuki Y; Takahashi M
    J Radiat Res; 2022 Jan; 63(1):80-87. PubMed ID: 34718690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.